stars 1 stars 2 stars 3

BioLamina is a biotechnology company with a scientific base and heritage in matrix biology and cell culture research. It supports scientists who have struggled for decades to grow pluripotent stem cells and other primary cells in the lab. By providing tools for efficient and easy cell culture, BioLamina aims to ease the path towards safe and effective cell therapies and make better cell assays and models for increasing accuracy in drug discovery and development. The power of Biolaminin® substrates, developed by BioLamina, has been demonstrated in numerous publications, and they will continue to provide vital support to the stem cell community, from scientific concepts to clinical studies.

BioLamina Questions

The BioLamina annual revenue was $18.6 million in 2026.

Klaus Langhoff-Roos is the CEO of BioLamina.

96 people are employed at BioLamina.

BioLamina is based in Sundbyberg, Stockholm.

The NAICS codes for BioLamina are [54171, 541713, 541, 54, 5417].

The SIC codes for BioLamina are [87, 873].

Top BioLamina Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users